Webinar on the Toxic Substances Control Act (TSCA) implementation

Home / Community Blog / Webinar on the Toxic Substances Control Act (TSCA) implementation

Community Blog

Webinar on the Toxic Substances Control Act (TSCA) implementation

You are cordially invited to attend a webinar on
Toxic Substances Control Act (TSCA) Implementation

Monday, March 27, 12 – 1:30 p.m. EST Program

On Monday, March 27, Gradient and Covington will host a webinar on the Toxic Substances Control Act (TSCA) implementation, featuring a guest speaker from the U.S. Environmental Protection Agency involved in the TSCA reform. TSCA was amended in June 2016 by the Frank R. Lautenberg Chemical Safety for the 21st Century Act (LCSA), which substantially changes how chemical safety is evaluated under TSCA.

This three-part series will include a second session on April 19 featuring EPA Acting Science Advisor Robert Kavlock, former EPA General Counsel E. Donald Elliot and Gradient’s Senior Toxicologist Dr. Lisa Bailey on the role of new exposure information strategies, and The Humane Society of the United States’ Dr. Kate Willett on non-animal testing data in implementing the LCSA.  A third session will be held in May featuring former EPA General Counsel Gary Guzy and Lorenz Rhomberg on the implication of the LCSA for State regulation of chemicals and comparisons with other risk assessment schemes.

Use this link for registration.  Log-In Details Will be sent to registered attendees closer to the date of the event.

March 27 Speakers:

  • Brian Grant, Assistant General Counsel at the U.S. Environmental Protection Agency, will discuss the new law and what EPA has done and is doing under it.
  • Thomas Brugato, an attorney with Covington’s environmental and litigation practices, will provide perspective on the key legal changes of the Act.  In particular, he will comment on the legal challenges and opportunities presented by these amendments, as well as the timeline for implementation.
  • Dr. Jessie Kneeland, senior environmental chemist at Gradient, will highlight some of the key scientific issues raised by the Act, including new and existing chemical safety evaluations, new data needs, and confidential business information CBI claims.

Moderated by:

Leave a Comment

*